Pricing Log in Create free account

Acrivon Therapeutics, Inc. (ACRV) vs Cardiff Oncology, Inc. (CRDF)

Acrivon Therapeutics, Inc. and Cardiff Oncology, Inc. are both Biotechnology companies. Acrivon Therapeutics, Inc. and Cardiff Oncology, Inc. are of similar size ($75.5M and $75.4M). Acrivon Therapeutics, Inc. has the higher net margin (0.00% vs −7,889.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 12 metrics below, Acrivon Therapeutics, Inc. leads on 7 and Cardiff Oncology, Inc. on 5.

Valuation

Metric ACRV CRDF Biotechnology median
P/E n/m n/m 8.50
P/S n/m 122.52 9.71
P/B 0.79 2.35 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.28 n/m 0.64
EV/Sales n/m 57.34 9.21
Earnings yield (114.63%) (65.93%) (33.15%)
Free cash flow yield (93.47%) (65.78%) (25.50%)

Profitability

Metric ACRV CRDF Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (8,320.08%) 0.00%
Net margin 0.00% (7,888.98%) 0.00%
Free cash flow margin 0.00% (8,059.45%) 0.00%
Return on equity (64.63%) (94.14%) (56.36%)
Return on assets (57.61%) (70.89%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ACRV CRDF Biotechnology median
Revenue growth (TTM) — (6.79%) 6.02%
EPS growth (last fiscal year) 15.13% 27.37% 30.26%
Revenue growth, 5-year CAGR — 10.13% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ACRV CRDF Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 7.99 3.30 4.72
Net debt to EBITDA 1.43 1.18 0.96

Dividend

Metric ACRV CRDF Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric ACRV CRDF Biotechnology median
Market cap 75.42m 75.54m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack